Fresenius Kabi is raising the bar in responsible antibiotic manufacturing

July 11, 2025

Antimicrobial resistance (AMR) is one of the most pressing global health challenges of our time. While access to antibiotics is essential, how we manufacture them plays a critical role in safeguarding public health – today and for future generations.

That is why we are proud to share that our Santiago de Besteiros site in Portugal has received a big step towards our ongoing commitment to responsible antibiotic manufacturing: BSI Kitemark™ Certification for Minimized Risk of AMR in the production of Ceftriaxone, a vital antibiotic used to treat and prevent bacterial infections.

This certification confirms that our manufacturing processes meet the AMR Industry Alliance’s Antibiotic Manufacturing Standard. It also recognizes our efforts to:

  • Minimize the release of antibiotic residues into wastewater
  • Control emissions of antibiotic residues in waste streams during manufacturing
  • Promote responsible pharmaceutical production
Aerial view of Fresenius Kabi’s antibiotic manufacturing site in Portugal with factory buildings and surrounding infrastructure
At Santiago de Besteiros, in the heart of Portugal, Fresenius Kabi, remains one of the last major manufacturers still producing antibiotics in Europe.
Our mission is to save lives. As one of the largest antibiotic manufacturers in Europe, it is our responsibility to ensure that the antibiotics produced at the Santiago de Besteiros plant are effective. That’s why we embraced the challenge of achieving AMR certification with great enthusiasm. And we are proud to say that we are the first Fresenius Kabi plant to receive this certification.

Cristina Fernandes, Plant Manager at Santiago de Besteiros, Portugal

Cristina Fernandes Plant Manager

This achievement reflects the dedication and expertise of the Fresenius Kabi team in Santiago de Besteiros and beyond. Our commitment to excellence is helping us lead the way for the future, because the way we manufacture today shapes the effectiveness of antibiotics tomorrow.

Group photo of Fresenius Kabi staff in protective clothing at antibiotic production facility in Portugal
A proud moment for our team in Portugal: Raising the bar in responsible antibiotic manufacturing
Responsible antibiotic manufacturing is how we protect both the environment and the miracle of antibiotics – preserving their power for those who will need them tomorrow. AMR, the silent pandemic, demands more than responsible use, it demands responsibility at the source.

Zyad Hatquai, Manager Sustainability EHS Management at Fresenius Kabi

Zyad Hatquai EHS Portugal

Related Content